Glioblastoma eroding through falx cerebri: a rarity or commonly seen? Illustrative case Authors: Stefan P. Roch, Anatoli Pinchuk, Daniel Behme, Klaus-Peter Stein, Belal Neyazi, I. Erol Sandalcioglu, Ali Rashidi Published: 2025 ABSTRACT BACKGROUNDGlioblastoma, isocitrate dehydrogenase–wildtype CNS WHO grade 4 (formerly primary glioblastoma multiforme), is the most common and most malignant primary brain tumor. High-grade gliomas most commonly present as unifocal lesions; however, they invade the brain parenchyma in a diffuse manner, an attribute that renders successful resection difficult. Resection, wherein resection of more than 90% of the tumor mass must be achieved to improve outcomes, represents the first step in optimal treatment; therefore, surgical planning, approach, and technique are of utmost importance for successful treatment.OBSERVATIONSIn this paper, the authors present a rare case of a glioblastoma presenting as an atypical bilateral lesion with erosion through the falx cerebri. Morphologically, it was overtly distinct from a typical butterfly glioma. Initially, the authors believed this tumor to be a meningioma, or even a sarcoma, based on radiological morphology. Intraoperatively, destruction of the falx cerebri by the tumor, with spread to the contralateral hemisphere, was seen.LESSONSTo the best of the authors’ knowledge, the erosion of the falx cerebri has not been previously described in glioblastoma in the literature, and this case highlights the importance of a thorough differential diagnosis and understanding its impact on surgical planning. https://thejns.org/doi/10.3171/CASE25410 Glioblastoma, isocitrate dehydrogenase (IDH)–wildtype CNS WHO grade 4 (formerly primary glioblastoma multiforme), is the most common and most malignant primary type of brain tumor.1 Glioblastomas make up 20%–30% of all primary brain tumors. The incidence rate of gliomas in various studies shows a range of 3.09–5.73 per 100,000 persons per year, with a male predominance (1.25/1.5 male-to-female ratio);2,3 among the group of high-grade gliomas, they account for 76% of cases.4 In most cases, gliomas present as unilocular lesions in the hemispheres of the telencephalon;5 specifically for glioblastomas, around 5% of cases may manifest in bi- or multifocal lesions, where they may not only take the form of morphologically distinct butterfly gliomas, but also carry worse prognoses.6 The butterfly glioma typically involves the corpus callosum and extends into both hemispheres, morphologically mimicking a butterfly. The majority of these gliomas involve the genu of the corpus callosum; in exceedingly rare instances, around 0.5%, glioblastomas are even capable of forming extra-axial metastatic lesions.7 Gliomas that infiltrate the falx cerebri, such as glioblastomas, can present with radiological features similar to those of meningiomas, making diagnosis challenging, as these tumors may exhibit a heterogeneous appearance on imaging, often leading to misdiagnosis. Falx meningiomas are extra-axial tumors, while glioblastomas can infiltrate the falx cerebri, leading to significant clinical implications.8 Typical radiological features of meningioma that differentiate it from glioblastoma include a broad dural attachment, calcification, and usually a lack of invasion to the brain parenchyma, although this feature is commonly seen in higher-grade meningiomas. Both meningiomas and glioblastomas may exhibit central necrosis without contrast enhancement, as well as a dural tail sign.9,10 The presence of edema and visualization of a tumor’s characteristics on MRI can help to differentiate between these two types of tumors, although overlap in presentation can occur.8 To help with differential diagnosis, advanced imaging techniques, such as perfusion MRI or 11C-methionine PET-MRI, may be deployed, as these techniques can be used to recognize areas with altered perfusion or metabolism, respectively.11,12 Furthermore, MR spectroscopy (MRS) may aid in glioma diagnostics by allowing for the detection of brain metabolites, such as choline and N-acetyl aspartate; by mapping brain metabolites. Insight on the underlying tissue is obtained and, particularly in combination with perfusion MRI, the diagnostic accuracy for glioma is improved over conventional contrast-enhanced MRI.13,14 As taken up in the 2021 WHO classification of CNS tumors, glioblastoma is characterized by IDH-wildtype and other genetic identifiers, including telomere reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) amplification, addition of chromosome 7, and loss of chromosome 10, and it confers poor prognosis among gliomas.15,16 The survival rates for glioblastoma are notably poor, with a 1-year survival rate of approximately 20.2% and a 2-year survival rate around 10%.17 Analysis of a large patient collective showed an increasing trend in survival from 2004 to 2013. Furthermore, younger patients, patients with O6-methylguanine-DNA methyltransferase (MGMT) methylation, and patients having received a trimodal therapy regimen, consisting of resection, chemotherapy, and radiotherapy, show a significantly better 3-year survival rate.18 The median survival for glioblastoma ranges from 9 to 15 months.19 However, in butterfly glioma, the median survival is significantly shorter, at 3.3–6 months.20 In summary, gliomas infiltrating the falx cerebri require careful evaluation to ensure accurate diagnosis and appropriate treatment planning. In this case report, we present a challenging case of a glioblastoma eroding the falx cerebri and, therefore, presenting as a bilateral lesion, which is overtly distinct from a butterfly glioma; this tumor was mimicking a falx meningioma, or even a sarcoma, on differential diagnosis. Illustrative Case A 63-year-old female patient was transferred to our university hospital following the diagnosis of an intracranial mass lesion, as imaged on a CT scan of the head. The patient presented to the emergency department with headache and dizziness persisting for 2 weeks. Her son had noticed a change in personality over the previous few months. The initial Karnofsky Performance Scale score was 90%–100%, and cranial MRI showed a large, bilateral, right-side-dominant frontal lesion with central necrosis, clearly crossing through the falx to the left frontal lobe (Fig. 1). In terms of differential diagnosis, glioblastoma, meningioma, and other rare pathologies such as sarcoma were considered. Since the corpus callosum was seemingly not the place of origin, nor part of the lesion, as Fig. 1 demonstrates, a glioblastoma was not deemed the most likely. FIG. 1.Axial (A), coronal (B and C), and sagittal (D) T1-weighted cranial contrast-enhanced MR images obtained at diagnosis. The arrows point to the structurally intact corpus callosum, not infiltrated by the tumor, indicating that this was not a classic butterfly glioma. Axial (A), coronal (B and C), and sagittal (D) T1-weighted cranial contrast-enhanced MR images obtained at diagnosis. The arrows point to the structurally intact corpus callosum, not infiltrated by the tumor, indicating that this was not a classic butterfly glioma. The patient underwent fluorescence, navigation, and ultrasound-guided microsurgical resection via a right unilateral frontal craniotomy. The tumor was grossly resected on the right side. Intraoperatively, a clear destruction of the falx was seen, in addition to a crossing of the tumor to the left frontal lobe. The tumor on the left side was subtotally resected due to tumor invasion into the branches of the anterior cerebral artery. The postoperative course was uneventful, with the patient presenting no new neurological deficits. Early postoperative MRI showed small tumor remnants on the left side (Fig. 2). Histopathological results identified glioblastoma, CNS WHO grade 4, MGMT methylated, IDH1 and IDH2 wildtype, TERT promotor wildtype, and absence of 1p/19q codeletion. Further mutations were found in position A289V of the EGFR gene, as well as its amplification, and tumor protein p53 showed a splice acceptor variant. FIG. 2.Axial (left) and coronal (right) T1-weighted cranial contrast-enhanced MR images obtained following resection of the bifrontal lesion. The arrows indicate residual tumor. Axial (left) and coronal (right) T1-weighted cranial contrast-enhanced MR images obtained following resection of the bifrontal lesion. The arrows indicate residual tumor. On postoperative day 5, the patient developed a deep venous thrombosis despite daily subcutaneous prophylactic low-molecular-weight heparin injections. CT angiography of the chest showed a bilateral central lung embolism. The patient was asymptomatic and was transferred to our neurosurgical ICU to begin therapeutic heparinization. She returned promptly to the ward and was switched to novel oral anticoagulants. On postoperative day 12, the patient was discharged to continue radio- and chemotherapy treatments according to the Stupp protocol. At 5 months following surgery, she returned to our clinic with a change in personality over the previous 2 weeks, according to her son. Furthermore, she had experienced a generalized seizure for the first time 10 days prior. Dexamethasone and levetiracetam were started. She had undergone radiation treatment following the Stupp protocol, as well as temozolomide chemotherapy. Cranial MRI with perfusion sequences led to a diagnosis of radiation necrosis (Fig. 3). FIG. 3.Axial perfusion (left) and T1-weighted cranial MR (right) images obtained at the 5-month follow-up. The arrows point to corresponding areas demonstrating hypoperfusion on perfusion sequences, yet contrast enhancement in the T1-weighted image. Axial perfusion (left) and T1-weighted cranial MR (right) images obtained at the 5-month follow-up. The arrows point to corresponding areas demonstrating hypoperfusion on perfusion sequences, yet contrast enhancement in the T1-weighted image. At the 8-month follow-up, another cranial MRI study with perfusion showed tumor progression according to the Response Assessment in Neuro-Oncology criteria, with a new lesion on the posterior wall of the fourth ventricle. Interestingly, the primary bifrontal lesion still showed no clear hyperperfusion on perfusion sequences and, therefore, no local progression. The patient decided not to undergo any further treatment and was lost to follow-up. Informed Consent The necessary informed consent was obtained in this study. Discussion Observations This case of glioblastoma presented as an atypical, bilateral, falx-crossing lesion on cranial contrast-enhanced MRI. Initially, the lesion radiomorphologically resembled a meningioma or sarcoma. Since there was a possibility for the lesion to, in fact, be a glioblastoma based on preoperative MRI, although it was not the main suspicion, the patient received 5-aminolevulinic acid (5-ALA) preoperatively. Following intraoperative morphology under 5-ALA fluorescence and frozen-section results, the goal was switched to maximizing resection margins. Via the unilateral approach, it proved difficult to access the left-sided lesion in a transfalcine manner. For similar future cases, glioblastoma should be considered in the differential diagnosis. Consequently, a bilateral approach could have been chosen and improved resection margins and, therefore, improved the surgical outcome and extent of resection. Glioblastomas, particularly those infiltrating the falx cerebri, present significant challenges in both diagnosis and treatment due to their aggressive nature and the overlapping radiological features they share with meningiomas. The falx cerebri, a crescent-shaped fold of dura mater, is a common site for both glioblastomas and meningiomas, leading to diagnostic confusion that can have serious implications for patient management and outcomes. Furthermore, in cases similar to this bilateral glioblastoma, a clear distinction to a classical butterfly glioma ought to be made, due to its distinct therapy and prognosis.21 Glioblastomas are known for their infiltrative growth patterns, which can obscure the boundaries between the tumor and surrounding brain tissue, a characteristic that complicates resection, as complete removal of the tumor may be impossible without damaging critical brain structures. The infiltrative nature of these tumors also poses a risk of recurrence, as residual tumor cells can lead to regrowth even after a seemingly successful surgery;22 in this case study, we were faced with a similar issue. Patients with glioblastomas may present with symptoms that are not distinct from those of meningiomas, such as headaches, seizures, and neurological deficits. Such nonspecific symptomatology can further complicate the diagnostic process, as clinicians may not immediately suspect a glioblastoma when the clinical picture aligns more closely with that of a meningioma.3 Misdiagnosing a glioblastoma as a meningioma can lead to inappropriate treatment strategies, as meningiomas are often treated with resection and may not require aggressive adjuvant therapies such as chemotherapy and radiation therapy, which are standard for glioblastomas. Mismanagement can significantly worsen patient prognosis.23 If a glioblastoma is misidentified as a meningioma, the delay in receiving the correct diagnosis can allow the tumor to progress, leading to a more advanced stage at the time of appropriate intervention, a delay that can reduce the effectiveness of treatment options and negatively impact survival rates.24 Utilizing advanced imaging modalities, such as MRS and perfusion-weighted MRI, can help to differentiate between glioblastomas and meningiomas. MRS can provide metabolic information that may indicate malignancy, while perfusion imaging can be used to assess blood flow characteristics that differ between tumor types.22 A definitive diagnosis should be confirmed through the histopathological examination of biopsy samples. Immunohistochemical staining can help to differentiate glioblastomas from meningiomas based on specific markers, such as glial fibrillary acidic protein positivity in glioblastomas.25 A collaborative approach involving neurosurgeons, radiologists, and oncologists can enhance diagnostic accuracy. Regular case discussions and tumor board meetings can facilitate the sharing of insights and experiences, leading to more informed decision-making regarding diagnosis and treatment strategies.26 Establishing clear clinical guidelines for the evaluation of brain tumors can help to standardize the diagnostic process, as these guidelines should emphasize the importance of considering glioblastoma in differential diagnoses, especially in cases with atypical presentations or locations.4 In Table 1, we present other case reports found to date through a PubMed search of glioblastoma mimicking meningioma.8,17,24,25 TABLE 1.Summary of cases in which glioblastoma mimicked meningiomaAuthors & YearFindingsRadiological MorphologyPresent case63-yr-old female, headache, dizziness, change in personalityBifrontal lesion, directly eroding through falx cerebri to contralat hemisphereVarma et al., 2020830-yr-old female, focal to generalized seizureBifrontal lesion, adherent to falx cerebri, but no invasion describedSong et al., 20242555-yr-old male, gait disturbance, dysarthria, dizzinessInterhemispheric bifrontal lesions, no data on falx invasivenessKayaci et al., 20141719-yr-old male, achondroplasia, headache, nausea, dizzinessLt parasagittal frontoparietal lesion, adherent to falx cerebri, but no falx invasion describedPatel et al., 201624Case 1: 57-yr-old female, headache, ataxia, memory deficits; case 2: 60-yr-old male, rt hemiparesisCase 1: rt temporal lesion, adherent to tentorium, but no invasion described; case 2: lt parasagittal lesion w/ dural tail sign, but no falx invasion TABLE 1.Summary of cases in which glioblastoma mimicked meningiomaAuthors & YearFindingsRadiological MorphologyPresent case63-yr-old female, headache, dizziness, change in personalityBifrontal lesion, directly eroding through falx cerebri to contralat hemisphereVarma et al., 2020830-yr-old female, focal to generalized seizureBifrontal lesion, adherent to falx cerebri, but no invasion describedSong et al., 20242555-yr-old male, gait disturbance, dysarthria, dizzinessInterhemispheric bifrontal lesions, no data on falx invasivenessKayaci et al., 20141719-yr-old male, achondroplasia, headache, nausea, dizzinessLt parasagittal frontoparietal lesion, adherent to falx cerebri, but no falx invasion describedPatel et al., 201624Case 1: 57-yr-old female, headache, ataxia, memory deficits; case 2: 60-yr-old male, rt hemiparesisCase 1: rt temporal lesion, adherent to tentorium, but no invasion described; case 2: lt parasagittal lesion w/ dural tail sign, but no falx invasion Summary of cases in which glioblastoma mimicked meningioma The presented case herein differs from the listed cases by demonstrating erosion through the falx cerebri and, thereby, presenting as a bilateral lesion, yet being morphologically and genetically different from a butterfly glioma. This is an exceedingly rare feature of glioblastoma. If known beforehand, it would have resulted in a different, bifrontal surgical approach aiming for resection of greater than 89% of tumor volume. Finally, we summarize shared and unique radiological features of glioblastomas and meningiomas (Table 2).910,12,27 TABLE 2.Radiological features of glioblastomas compared to meningiomasGlioblastomaMeningiomaDural attachment−++Dural tail sign−++Central necrosis+++−/+Calcification−++Brain invasion+++−/+Edema++−/+Contrast enhancement+/−++Homogeneity−−−+Bilaterality−/+−/+Bone erosion−−/++ = usually present; ++ = often present; +++ = mostly present; − = usually not present; −−− = rarely present. TABLE 2.Radiological features of glioblastomas compared to meningiomasGlioblastomaMeningiomaDural attachment−++Dural tail sign−++Central necrosis+++−/+Calcification−++Brain invasion+++−/+Edema++−/+Contrast enhancement+/−++Homogeneity−−−+Bilaterality−/+−/+Bone erosion−−/++ = usually present; ++ = often present; +++ = mostly present; − = usually not present; −−− = rarely present. Radiological features of glioblastomas compared to meningiomas + = usually present; ++ = often present; +++ = mostly present; − = usually not present; −−− = rarely present. Lessons In conclusion, glioblastomas, particularly those infiltrating the falx cerebri and other dural folds, pose significant diagnostic and treatment challenges due to their aggressive nature and radiological similarity to less aggressive meningiomas. Initial misdiagnosis can lead to inappropriate treatment, starting at surgical approach planning, and may result in poorer outcomes by delaying necessary treatment. Implementing advanced imaging techniques, thorough histopathological analysis, and a multidisciplinary approach can facilitate more accurate diagnoses and improve patient management. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: Rashidi. Acquisition of data: Roch, Pinchuk, Neyazi, Rashidi. Analysis and interpretation of data: Roch, Behme, Sandalcioglu, Rashidi. Drafting the article: Roch, Behme, Sandalcioglu, Rashidi. Critically revising the article: Roch, Stein, Behme, Neyazi, Sandalcioglu, Rashidi. Reviewed submitted version of manuscript: Roch, Stein, Rashidi. Approved the final version of the manuscript on behalf of all authors: Roch. Administrative/technical/material support: Roch, Behme, Rashidi. Study supervision: Sandalcioglu, Rashidi. Correspondence Stefan P. Roch: Otto von Guericke University, Magdeburg, Saxony-Anhalt, Germany. stefan.roch@med.ovgu.de.